Stay updated on Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page
- ChecktodayChange DetectedThe site footer revision marker changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the detailed study content with a minimal error screen. Only navigation elements like Home and the site footer remain, blocking access to core trial information.SummaryDifference23%

- Check35 days agoChange DetectedThe study's update log was modified to include two new dates (2026-09-01 and 2026-08-29) and remove two earlier dates (2026-08-28 and 2026-08-27), indicating administrative record-keeping rather than changes to the study itself.SummaryDifference0.1%

- Check42 days agoChange DetectedThe revision log was updated with new entries dated 2026-08-27 and 2026-08-28 and a new Revision: v3.6.6. Older revisions dated 2026-08-18 and 2026-08-19 and Revision: v3.6.5 appear to have been removed.SummaryDifference0.2%

- Check49 days agoChange DetectedNew update dates were added: 2026-08-19, 2026-08-18, and 2026-08-17, while older update dates 2026-08-13, 2026-08-12, and 2026-05-06 were removed from the record.SummaryDifference0.2%

- Check56 days agoChange Detected- The study record's update history now shows two new dates (2026-08-12 and 2026-08-13), expanding the timeline of recent updates. Earlier dates visible in the history appear to be removed.SummaryDifference0.2%

Stay in the know with updates to Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.